Dewpoint Therapeutics

Boston, MA · Founded 2018 · Privately Held (backing)

Developer of an AI-powered healthcare technology platform designed to identify novel drugs across a wide spectrum of diseases. Dewpoint Therapeutics is based in Boston, MA and was founded in 2018. Its last reported valuation was $500 million in Feb 2022. It has raised $345 million across 3 recorded rounds; the latest was a $59.1 million later-stage round in Sep 2025.

Last reported valuation
$500.0M
Oct 2026
Priced at
—
Total raised
$345.3M
Last round
Later Stage VC
Sep 2025
What is Dewpoint Therapeutics worth?
$500.0Mlast reported valuation · Oct 2026

Dewpoint Therapeutics's last reported valuation, Feb 2022. Nothing priced has surfaced since.

Free account
More of Dewpoint Therapeutics with a free account
  • ·The complete investor list: 18 names
  • ·Watch Dewpoint Therapeutics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Valuation timeline

0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026
▮▮
Markrounds hold their value until the next priced eventMark, today
log scale
Post-money values unlock with a free account.Unlock the axis

Membership and data by Private Market View

Dewpoint Therapeutics funding history

3 rounds
DateRoundRaisedPost-money
Sep 2025Later Stage VC$59.1M▮
Jan 2022Later Stage VC$150.0M▮
Jul 2020Later Stage VC$77.1M▮
Unlock post-money valuations

Membership and data by Private Market View

Dewpoint Therapeutics valuation

Dewpoint Therapeutics's last reported valuation was $500 million in Feb 2022. No priced round, secondary trade or fund mark has surfaced since.

How much has Dewpoint Therapeutics raised?

Dewpoint Therapeutics has raised $345 million across 3 recorded rounds since 2020. The largest was a $77.1 million later-stage round in Jul 2020; the most recent was a $59.1 million later-stage round in Sep 2025.

Dewpoint Therapeutics has filed 3 Form Ds with the SEC since 2020, most recently in Sep 2025 ($59.1 million sold to 21 investors).

How Dewpoint Therapeutics's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For Dewpoint Therapeutics, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by last reported valuation. Question about this number? Full methodology →

Frequently asked about Dewpoint Therapeutics

What is Dewpoint Therapeutics worth?
Dewpoint Therapeutics is valued at $500.0M as of Oct 2026. Dewpoint Therapeutics's last reported valuation, Feb 2022. Nothing priced has surfaced since.
How much has Dewpoint Therapeutics raised?
Dewpoint Therapeutics has raised $345.3M in total funding across 3 recorded rounds.
When did Dewpoint Therapeutics last raise?
Dewpoint Therapeutics last raised in Sep 2025 (Later Stage VC), raising $59.1M.